⌘K
Loading ticker…
As of 2026-08-24, Oruka Therapeutics, Inc. Common Stock (ORKA) has a 3-month relative strength percentile of 96 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 97. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.7%, relative volume 1.23×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
ORKA is in a stage 2 uptrend, week 11. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 11.2% / 85.5%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
ORKA is held by 26 ETFs as of May 2026. Top owner: VTWO at 0.08% weight, $14M notional. Top 3 carry $33M.
Held by 47 ETFs · $270M across latest filings · largest weight 1.81% (SBIO).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.08% | $14M | +0.04 pp |
| SCHASchwab U.S. Small-Cap ETF | 0.06% | $14M | +0.03 pp |
| VHTVanguard Health Care ETF | 0.03% | $6M | +0.02 pp |
| AVSC | 0.17% | $5M | +0.09 pp |
| CGMM | 0.11% | $3M | new |
Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 1.81% |
| $3M |
| +0.73 pp |
| VFMO | 0.14% | $3M | −0.02 pp |
| DWAS | 0.57% | $2M | +0.16 pp |
| VTWV | 0.17% | $2M | +0.08 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $2M | — |
Showing 10 of 26 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ORKA Jan avg: -8.85% median: -8.85% win: 50% σ: 30.81% n: 2 2024-09-04 → 2026-07-31 | ORKA Feb avg: -12.01% median: -12.01% win: 50% σ: 17.72% n: 2 2024-09-04 → 2026-07-31 | ORKA Mar avg: 21.82% median: 21.82% win: 100% σ: 29.32% n: 2 2024-09-04 → 2026-07-31 | ORKA Apr avg: 20.61% median: 20.61% win: 100% σ: 26.67% n: 2 2024-09-04 → 2026-07-31 | ORKA May avg: -4.73% median: -4.73% win: 50% σ: 13.73% n: 2 2024-09-04 → 2026-07-31 | ORKA Jun avg: 32.44% median: 32.44% win: 100% σ: 42.65% n: 2 2024-09-04 → 2026-07-31 | ORKA Jul avg: 11.32% median: 11.32% win: 100% σ: 14.02% n: 2 2024-09-04 → 2026-07-31 | ORKA Aug avg: 8.90% median: 8.90% win: 100% σ: 0.00% n: 1 2024-09-04 → 2026-07-31 (current) | ORKA Sep avg: 13.03% median: 13.03% win: 50% σ: 23.91% n: 2 2024-09-04 → 2026-07-31 | ORKA Oct avg: 30.36% median: 30.36% win: 100% σ: 22.80% n: 2 2024-09-04 → 2026-07-31 | ORKA Nov avg: -7.77% median: -7.77% win: 50% σ: 20.68% n: 2 2024-09-04 → 2026-07-31 | ORKA Dec avg: -5.04% median: -5.04% win: 50% σ: 8.11% n: 2 2024-09-04 → 2026-07-31 |